Enter a Search String |
| Special character and space not allowed in the query term. Search string should be at least 2 characters long. |
Molecule Parameter List for AA | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| The statistics table lists the distribution of a molecule acting either as a substrate, product, enzyme or as a molecule within the network. The text color of a molecule is highlighted by color. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Statistics | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| AA participated as | Molecule | Sum total of | Enzyme | Substrate of an enzyme | Product of an enzyme | Substrate in Reaction | Product in Reaction |
| No. of occurrences | 1 | 0 | 0 | 0 | 5 | 4 | 0 |
Accession and Pathway Details |
| Accession Name | Accession No. | Accession Type | Pathway Link |
2007_Bistable | 79 | Network | Shared_Object_Ajay_Bhalla_2007_Bistable, PKC, PLA2, MAPK, Ras, CaM |
| This is a model of ERKII signaling which is bistable due to feedback. The feedback occurs through ERKII phosphorylation of phospholipase A2 (PLA2), leading to increased production of arachidonic acid (AA), which activates protein kinase C (PKC) which activates c-Raf which is upstream of ERKII. The model is a highly simplified variant of more detailed bistable models of MAPK signaling (Bhalla US, Iyengar R. Science. 1999 Jan 15;283(5400):381-7, Ajay SM, Bhalla US. Eur J Neurosci. 2004 Nov;20(10):2671-80) | |||
AA acting as a Molecule in Ajay_Bhalla_2007_Bistable Network
| Name | Accession Name | Pathway Name | Initial Conc. (uM) | Volume (fL) | Buffered |
| AA | 2007_Bistable Accession No. : 79 | Ajay_Bhalla_ 2007_Bistable Pathway No. : 363 | 0 | 125.7 | No |
AA acting as a Product of an Enzyme in Ajay_Bhalla_2007_Bistable Network
| Enzyme Molecule / Enzyme Activity | Accession Name | Pathway Name | Km (uM) | kcat (s^-1) | Ratio | Enzyme Type | Reagents | |
| 1 | PLA2-Ca* / kenz | 2007_Bistable Accession No. : 79 | PLA2 Pathway No. : 365 | 19.9997 | 5.4 | 4 | explicit E-S complex | Substrate APC Product AA |
| 10 x raise oct22 12 x oct 24, set k2 = 4 * k3 | ||||||||
| 2 | PIP2-PLA2* / kenz | 2007_Bistable Accession No. : 79 | PLA2 Pathway No. : 365 | 20 | 11.04 | 4 | explicit E-S complex | Substrate APC Product AA |
| 10 X raise oct 22 12 X further raise oct 24 to allow for correct conc of enzyme | ||||||||
| 3 | PIP2-Ca-PLA2* / kenz | 2007_Bistable Accession No. : 79 | PLA2 Pathway No. : 365 | 20.0003 | 36 | 4 | explicit E-S complex | Substrate APC Product AA |
| 10 x raise oct 22 12 x and rescale for k2 = 4 * k3 convention oct 24 Increase further to get the match to expt, which was spoilt due to large accumulation of PLA2 in the enzyme complexed forms. Lets raise k3, leaving the others at k1 = 1.5e-5 and k2 = 144 since they are large already. | ||||||||
| 4 | DAG-Ca-PLA2* / kenz | 2007_Bistable Accession No. : 79 | PLA2 Pathway No. : 365 | 19.9996 | 60 | 4 | explicit E-S complex | Substrate APC Product AA |
| 10 X raise oct 22 12 X raise oct 24 + conversion to k2 =4 * k3 | ||||||||
| 5 | PLA2*-Ca / kenz | 2007_Bistable Accession No. : 79 | PLA2 Pathway No. : 365 | 20.0001 | 120 | 4 | explicit E-S complex | Substrate APC Product AA |
| This form should be 3 to 6 times as fast as the Ca-only form. I have scaled by 4x which seems to give a 5x rise. 10x raise Oct 22 12 x oct 24, changed k2 = 4 * k3 | ||||||||
AA acting as a Substrate in a reaction in Ajay_Bhalla_2007_Bistable Network
| Kd is calculated only for second order reactions, like nA+nB <->nC or nA<->nC+nD, where n is number and A,B,C,D are molecules, where as for first order reactions Keq is calculated. Kd for higher order reaction are not consider. |
| Name | Accession Name | Pathway Name | Kf | Kb | Kd | tau | Reagents | |
| 1 | 2007_Bistable Accession No. : 79 | PKC Pathway No. : 364 | 0.0012 (uM^-1 s^-1) | 0.1 (s^-1) | Kd(bf) = 83.3326(uM) | - | Substrate AA PKC-Ca Product PKC-Ca-AA* | |
| Schaechter and Benowitz We have to increase Kf for conc scaling Changed kf to 2e-9 on Sept 19, 94. This gives better match. | ||||||||
| 2 | PKC-act-by-AA | 2007_Bistable Accession No. : 79 | PKC Pathway No. : 364 | 0.0001 (uM^-1 s^-1) | 0.1 (s^-1) | Kd(bf) = 833.3264(uM) | - | Substrate AA PKC-cytosolic Product PKC-AA* |
| Raise kf from 1.667e-10 to 2e-10 to get better match to data. | ||||||||
| 3 | PKC-n-DAG-AA | 2007_Bistable Accession No. : 79 | PKC Pathway No. : 364 | 0.018 (uM^-1 s^-1) | 2 (s^-1) | Kd(bf) = 111.113(uM) | - | Substrate AA PKC-DAG Product PKC-DAG-AA |
| Reduced kf to 0.66X to match Shinomura et al data. Initial: kf = 3.3333e-9 New: 2e-9 Newer: 2e-8 kb was 0.2 now 2. | ||||||||
| 4 | Degrade-AA | 2007_Bistable Accession No. : 79 | PLA2 Pathway No. : 365 | 0.4 (s^-1) | 0 (s^-1) | - | - | Substrate AA Product APC |
| I need to check if the AA degradation pathway really leads back to APC. Anyway, it is a convenient buffered pool to dump it back into. For the purposes of the full model we use a rate of degradation of 0.2/sec Raised decay to 0.4 : see PLA35.g notes for Feb17 | ||||||||
color.